Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

951
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
951
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

181
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
181
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.0K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.0K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

112
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
112
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

340
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
340
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

477
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
477

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing advanced DMEM/F-12 cell culture medium to mitigate glycerol toxicity in poultry semen.

British poultry science·2026
Same author

Impact of the COVID-19 Pandemic on 30-Day Readmission Rates in Hospitalized Stroke Patients: A Retrospective Cohort Study.

Journal of central nervous system disease·2025
Same author

Can bladder neck thickness on magnetic resonance imaging (MRI) predict early outcomes after anatomic enucleation of the prostate (AEEP) in benign prostatic hyperplasia patients with small-volume prostate?

Clinical radiology·2025
Same author

Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis.

Beneficial microbes·2024
Same author

Regulation of epidermal growth factor receptor tyrosine kinase inhibitor resistance via Ambra1-mediated autophagy in non-small cell lung cancer.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

Social association predicts immunological similarity in rewilded mice.

bioRxiv : the preprint server for biology·2023

Related Experiment Video

Updated: Aug 17, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

495

Predicting adverse drug effects: A heterogeneous graph convolution network with a multi-layer perceptron approach.

Y-H Chen1,2, Y-T Shih3, C-S Chien3

  • 1Dept. of Nephrology, Taichung Tzu Chi Hospital, Taichung, Taiwan.

Plos One
|December 14, 2022
PubMed
Summary

This study introduces a novel computational method, GCNMLP, to predict potential drug side effects using graph convolution networks. The approach efficiently uncovers unseen drug side effects, improving upon existing machine learning techniques.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Related Experiment Videos

Last Updated: Aug 17, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

495
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Area of Science:

  • Computational drug discovery
  • Pharmacovigilance
  • Bioinformatics

Background:

  • Identifying potential drug side effects is crucial for patient safety and drug development.
  • Existing methods for predicting drug side effects can be time-consuming and may miss subtle associations.
  • Integrating diverse drug and side effect data is essential for comprehensive analysis.

Purpose of the Study:

  • To develop and evaluate a novel in silico method, GCNMLP, for predicting potential drug side effects.
  • To leverage heterogeneous graph convolution networks (GCN) and multi-layer perceptrons (MLP) for enhanced side effect prediction.
  • To demonstrate the efficiency and superiority of the GCNMLP method compared to traditional approaches.

Main Methods:

  • Utilized heterogeneous graph convolution networks (GCN) combined with multi-layer perceptrons (MLP) for drug side effect prediction.
  • Integrated data from SIDER, OFFSIDERS, and FAERS datasets, focusing on drug characteristics and side effect networks.
  • Employed network inference to identify relationships between similar drugs and their associated side effects.

Main Results:

  • The GCNMLP method demonstrated superior performance compared to non-negative matrix factorization (NMF) and other machine learning methods across multiple evaluation metrics.
  • The model successfully predicted potential side effects for specific drugs, including Vancomycin, Amlodipine, Cisplatin, and Glimepiride.
  • The study successfully identified novel, previously undocumented side effects for investigated drugs.

Conclusions:

  • The GCNMLP approach offers a significant advancement in computational drug side effect discovery.
  • This in silico method can accelerate the identification of unseen side effects, reducing development time and improving drug safety.
  • The findings underscore the importance of exploring drug mechanisms through well-documented data and advanced network analysis.